Before treatment, there was no significant difference in serum IL-18 between the treatment group and the control group (P > 0.05), which was significantly higher than that of the normal healthy group. After 12 months of active treatment, the levels of inflammatory factors in the two groups were significantly lower than those before treatment (P < 0.05), but still significantly higher than those in the normal control group. The level of IL-18 in the treatment group was significantly lower than that in the control group (P < 0.05).<br>
正在翻译中..